Dapoxetine Completed Phase 1 Trials for Drug Interaction Potentiation Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT02485041Pharmacokinetic Interaction Study of Dapoxetine 30mg and Mirodenafil 100mg
NCT02485028Pharmacokinetic Interaction Study of Dapoxetine 30mg and Mirodenafil 50mg